Methallylescaline
Methallylescaline (MAL) is a synthetic psychedelic of the substituted phenethylamine class and a structural analog of mescaline. Its effects were first described by Alexander Shulgin in PiHKAL, with anecdotal reports suggesting it most closely resembles mescaline among the various mescaline analogs, producing both hallucinogenic and stimulant properties. Very little data exists regarding its pharmacology, metabolism, or toxicity, and it has minimal history of human use.
Contents
Dosage & Duration
Dosage
Methallylescaline has a steep dose-response relationship, meaning relatively small increases in the amount taken may result in disproportionately stronger effects. Careful attention to precise dosing is advisable.
Duration
Subjective Effects
Effects vary widely by individual, dose, and context.
Physical
Cognitive
Visual
Hallucinatory States
Auditory
Reagent Testing
Loading reagent data
Pharmacology
Pharmacodynamics
Methallylescaline acts as an agonist at serotonin 5-HT2 receptors, with primary activity at the 5-HT2A receptor. It has been described both as a potent 5-HT2A agonist and as a likely 5-HT2A partial agonist. It also interacts with the 5-HT2C receptor.
Pharmacokinetics
Tolerance
Psychedelics
Harm Potential
Addiction & Dependence
Psychological
Extremely LowMethallylescaline is not habit-forming, and the desire to use it can actually decrease with use. It is most often self-regulating.
Psychosis Risk
Delusion is listed among possible cognitive effects. Some reports mention experiences described as 'shades of what might become amnesia' and 'losing immediate contact,' though formal psychosis risk has not been evaluated due to the substance's limited research history.
History & Culture
Methallylescaline was first synthesized and explored by American chemist Alexander Shulgin, who initially experimented with the compound in 1981. The following year, in 1982, Shulgin discovered its hallucinogenic properties. He subsequently documented his findings in his 1991 book PiHKAL: A…
Trip Reports
Loading related reports
Preparing section content
Still loading. Refresh if this section does not appear.
Legality
By Country
Automated synthesisInformation aggregated and synthesized using an autonomous workflow built by Josie Kins.
Suggest an edit
Spotted a mistake, an outdated claim, or something missing from the Methallylescaline article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.
